← All organizations
Highest phase reached
Phase 2
First clinical trial
Oct 31, 2019Last known activity
Oct 31, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 3 trials)
Phase 2 (3 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (3)
- NCT06585020CollaboratorPhase 2Oct 31, 2024
- NCT04748796CollaboratorN/AFeb 1, 2021
- NCT04113226Overall official - principal investigatorPhase 2Oct 31, 2019
Details
- Last known activity
- Oct 31, 2024